FDA finalizes guidance on electronic submissions for OTC products

BY AMANDA CONTI

FDA has fulfilled its commitment under the Over-the-Counter Monograph Drug User Fee (OMUFA) program to issue final guidance on how sponsors can electronically submit monographs and other documents. The final document reflects the agency’s efforts to develop reference guides for its upload portals.

Fill out the form to read the full article.